Name
TICLOPIDINE
Mode of Action
IT CAUSES DOSE DEPENDENT INHIBITION OF PLATELET AGGREGATION AND RELEASE OF PLATELET GRANULE CONSTITUENTS AND PROLONGATION OF BLEEDING TIME. IT ALSO INHIBITS PLATELET, ADRENALINE AND PLATELET ACTIVATING FACTOR.
Dosage
ADULTS :- 250 MG TWICE DAILY WITH FOOD. CHILDREN :- NOT RECOMMENDED.
Drug Group
[ADP-INHIBITOR] , [ANTIPLATELET] , [PLATELET AGGREGATION INHIBITOR] , [PLATELET ACTIVATION & AGGREGATION INHIBITOR] , [P2Y12 RECEPTOR BLOCKER] , [ADENOSINE DIPHOSPHATE RECEPTOR BLOCKER] , [THIENOPYRIDINES]
Cross Reaction
RISK OF HAEMORRHAGE INCREASED WITH ASPIRIN AND ORAL ANTICOAGULANTS, INCREASE IN PIASMA LEVEL OF TICLOPIDINE WITH CIMETIDINE, INCREASE IN THEOPHYLLINE HALF-LIFE, DECREASES PLASMA DIGOXIN LEVELS.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph